Drug Testing Procurement Intelligence: Unlocking Opportunities for Growth
The drug testing category is expected to grow at a CAGR of 6.5% from 2023 to 2030. The key drivers of the market growth are the increasing consumption of alcohol by young people and the elderly, the overuse of prescribed medications, and the rising use of narcotics. The demand for drug testing is also anticipated to increase due to the increased instances of illegal drug use and the rising crime rates linked to drug misuse. There is more competition among manufacturers, and those developing innovative products across a wider range of categories are capturing a larger share of the market. Technologies such as gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and enzyme-linked immunosorbent assay (ELISA) are used in this category. Quest Diagnostics uses GC-MS technology, which identifies and quantifies drugs in complex biological samples and separates the components of a sample based on their volatility and mass-to-charge ratio. Labcorp uses ...